We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.03B
AUM Growth
-$287M
Cap. Flow
-$398M
Cap. Flow %
-38.68%
Top 10 Hldgs %
14.04%
Holding
1,478
New
335
Increased
269
Reduced
346
Closed
503

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Consumer Discretionary 12.74%
3 Healthcare 12.34%
4 Communication Services 10.34%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYLB icon
1151
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.48B
-28,910
Closed -$1.05M
IAI icon
1152
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.36B
-9,767
Closed -$1.37M
IBKR icon
1153
Interactive Brokers
IBKR
$39.8B
-28,428
Closed -$1.18M
ICE icon
1154
CALL
Intercontinental Exchange
ICE
$84.4B
-7,400
Closed -$1.28M
ICE icon
1155
Intercontinental Exchange
ICE
$84.4B
-2,120
Closed -$366K
ICLN icon
1156
iShares Global Clean Energy ETF
ICLN
$2.1B
-62,080
Closed -$709K
IE icon
1157
Ivanhoe Electric
IE
$1.74B
-16,582
Closed -$96.3K
IDXX icon
1158
Idexx Laboratories
IDXX
$46.2B
-512
Closed -$215K
IESC icon
1159
IES Holdings
IESC
$15.2B
-3,438
Closed -$568K
IKT icon
1160
Inhibikase Therapeutics
IKT
$388M
-11,098
Closed -$24.3K
IMO icon
1161
Imperial Oil
IMO
$60.4B
-3,657
Closed -$264K
IMNM icon
1162
Immunome
IMNM
$2.83B
-80,742
Closed -$543K
INDI icon
1163
indie Semiconductor
INDI
$854M
-12,399
Closed -$25.2K
INDV icon
1164
Indivior Pharmaceuticals
INDV
$4.58B
-26,758
Closed -$255K
INSP icon
1165
Inspire Medical Systems
INSP
$1.74B
-1,400
Closed -$223K
INTC icon
1166
Intel
INTC
$513B
-55,615
Closed -$1.26M
IOT icon
1167
Samsara
IOT
$23.8B
-5,231
Closed -$201K
IT icon
1168
Gartner
IT
$11.7B
-502
Closed -$211K
ITRG
1169
Integra Resources
ITRG
$521M
-17,361
Closed -$21.5K
ITT icon
1170
ITT
ITT
$19.1B
-2,384
Closed -$308K
IWM icon
1171
PUT
iShares Russell 2000 ETF
IWM
$81.9B
-7,000
Closed -$1.4M
J icon
1172
Jacobs Solutions
J
$17B
-1,802
Closed -$216K
JAZZ icon
1173
Jazz Pharmaceuticals
JAZZ
$16.7B
-1,615
Closed -$201K
JBHT icon
1174
JB Hunt Transport Services
JBHT
$25.2B
-2,147
Closed -$318K
JEF icon
1175
Jefferies Financial Group
JEF
$13.1B
-9,513
Closed -$510K

Similar funds

Prelude Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Prelude Capital Management held 1,478 positions worth $1.03B, down 22% from $1.32B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management withdrew a net $398M in Q2 2025, closing 503 positions and reducing 346 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Alphabet (Google) Class C worth $11.7M.

  • Prelude Capital Management's largest Q2 2025 buy was Alphabet (Google) Class C: 65,723 shares worth $11.7M.
  • Prelude Capital Management added most to Meta Platforms (Facebook) in Q2 2025, an estimated $12.3M increase.
  • Prelude Capital Management's biggest Q2 2025 reduction was Broadcom, cutting an estimated $9.33M.
  • Prelude Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $10.4M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.03B portfolio in Q2 2025.
  • Prelude Capital Management opened 335 new positions and closed 503 in Q2 2025.
  • Prelude Capital Management's portfolio value fell 22% quarter-over-quarter to $1.03B.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.